2012年～2014年我院心血管类中成药用药分析  

Medication analysis of cardiovascular Chinese patent medicine in outpatient clinic of our Hospital during 2012～2014

作　　者：刘建华[1] 

机构地区：[1]北京市昌平区中医医院,102200

出　　处：《首都食品与医药》2016年第14期63-66,共4页Capital Food Medicine

摘　　要：目的结合我院心血管病临床药物的用药情况,分析目前中成药治疗心血管病用药特点和趋势。方法对近3年心血管类中成药的种类、销售金额、用药频度等进行统计。结果我院心血管类中成药的销售金额逐年增加,银杏叶、复方丹参制剂为主流用药,近3年来用药金额和用药频度均排前列。结论心血管类中成药应用较为合理,符合安全、有效、经济的用药原则。Objective Combination of medication in our hospital clinical medicine of cardiovascular disease, the analysis of the current Chinese medicine for treating cardiovascular disease characteristics and trend of drugs. Method For the past three yeas of cardiovascular Chinese patent medicine category, sales amount, DDDs were statistically. Result The sales amount of cardiovascular Chinese patent medicine is increasing year by year, Ginkgo balboa, compound Danshen preparation for the mainstream medicine,In recent three years, the amount of medication and DDDs are front row. Conclusion Application of cardiovascular Chinese patent medicine is more reasonable, safe, effective, consistent with the principles of prescription of economy.

关 键 词：心血管类 中成药 用药分析 DDDS 销售金额 

分 类 号：R288[医药卫生—中药学]